{ "fields": [{"id":"_id","type":"int"},{"id":"ManufacturerName","type":"text"},{"id":"OrganizationType","type":"text"},{"id":"Country","type":"text"},{"id":"VaccineName","type":"text"},{"id":"VaccineSubName","type":"text"},{"id":"TradeName","type":"text"},{"id":"ProductionTechnology","type":"text"},{"id":"VaccineType","type":"text"},{"id":"CreateDate","type":"timestamp"}], "records": [ [1,"Abbott Biologicals","Public Organization","Netherlands","Influenza","Seasonal Influenza; Quadrivalent","Influvac","Primary culture technology","","2023-05-25T10:33:39"], [2,"Abbott Biologicals","Public Organization","Netherlands","Influenza","Seasonal Influenza; Quadrivalent","Influvac Tetra","Primary culture technology","","2023-05-25T10:33:39"], [3,"Abbott Biologicals","Public Organization","Netherlands","Influenza","Seasonal Influenza; Trivalent","Serinflu","Primary culture technology","","2023-05-25T10:33:39"], [4,"Adimmune","Public Organization","Taiwan","","","","","","2023-05-25T10:33:39"], [5,"AJ Vaccine (Staten Serum Institute)","Public Organization","Denmark","IPV","IPV","IPV Vaccine SSI ","Mammalian cell culture technology","","2023-05-25T10:33:39"], [6,"AJ Vaccine (Staten Serum Institute)","Public Organization","Denmark","IPV","IPV","PICOVAX","Mammalian cell culture technology","","2023-05-25T10:33:39"], [7,"AMSON","Public Organization","Pakistan","","","","","","2023-05-25T10:33:39"], [8,"AnGes","Public Organization","Japan","","","","","","2023-05-25T10:33:39"], [9,"Anhui Zhifei Longcom Biopharmaceutical","","China","Covid-19","Covid-19","Zifivax ","Mammalian cell culture technology","","2023-05-25T10:33:39"], [10,"Arabio","Public Organization","Saudi Arabia","","","","","","2023-05-25T10:33:39"], [11,"Arcturus Therapeutics","","United States of America","","","","","","2023-05-25T10:33:39"], [12,"AstraZeneca","Public Organization","United Kingdom of Great Britain and Northern Ireland","Covid-19","Covid-19","Vaxzevria","Mammalian cell culture technology","","2023-05-25T10:33:39"], [13,"Bavarian Nordic","Public Organization","Denmark","","","","","","2023-05-25T10:33:39"], [14,"Baxter","Public Organization","United States of America","","","","","","2023-05-25T10:33:39"], [15,"Beijing Bio-Institute of Biological Products","Public Organization","China","IPV","Sabin IPV","Sabin strain polio inactivated vaccine (Vero cells)","Mammalian cell culture technology","","2023-05-25T10:33:39"], [16,"Beijing Bio-Institute of Biological Products","Public Organization","China","MMR","MMR","Measles, Mumps and Rubella Combined Vaccine","Mammalian cell culture technology","","2023-05-25T10:33:39"], [17,"Beijing Minhai","Public Organization","China","","","","","","2023-05-25T10:33:39"], [18,"Beijing Zhifei Luzhu Biopharmaceutical","","China","","","","","","2023-05-25T10:33:39"], [19,"Berna Biotech","Public Organization","South Korea","Influenza","Seasonal Influenza; Trivalent","inflexal V","Primary culture technology","","2023-05-25T10:33:39"], [20,"Bharat Biotech","Public Organization","India","Covid-19","Covid-19","Covaxin","Mammalian cell culture technology","","2023-05-25T10:33:39"], [21,"Bharat Biotech","Public Organization","India","Rota","Rota","Rotavac","Mammalian cell culture technology","","2023-05-25T10:33:39"], [22,"Bharat Biotech","Public Organization","India","Rota","Rota","Rotavac 5D","Mammalian cell culture technology","","2023-05-25T10:33:39"], [23,"Biken","Public Organization","Japan","","","","","","2023-05-25T10:33:39"], [24,"Bilthoven Biologicals","Public Organization","Netherlands","IPV","IPV","Poliomyelitis vaccine","Mammalian cell culture technology","","2023-05-25T10:33:39"], [25,"Binnopharm","Public Organization","Russian Federation","","","","","","2023-05-25T10:33:39"], [26,"Biokangtai","Public Organization","China","Covid-19","Covid-19","Inactivated SARS-CoV-2 vaccine ","Mammalian cell culture technology","","2023-05-25T10:33:39"], [27,"Biological E. Limited","Public Organization","India","","","","","","2023-05-25T10:33:39"], [28,"Bio-Manguinhos/Fiocruz","Public Organization","Brazil","IPV","IPV","VACINA","Mammalian cell culture technology","","2023-05-25T10:33:39"], [29,"Bio-Manguinhos/Fiocruz","Public Organization","Brazil","MMR","MMR","Measles, mumps and rubella (MMR)","Mammalian cell culture technology","","2023-05-25T10:33:39"], [30,"Bio-Manguinhos/Fiocruz","Public Organization","Brazil","Rota","Rota","Human Rotavirus","Mammalian cell culture technology","","2023-05-25T10:33:39"], [31,"Bio-Med","Public Organization","India","","","","","","2023-05-25T10:33:39"], [32,"Biomed Lublin","Public Organization","Poland","","","","","","2023-05-25T10:33:39"], [33,"Bionet-Asia","Public Organization","Thailand","","","","","","2023-05-25T10:33:39"], [34,"BioNTech","Public Organization","Germany","","","","","","2023-05-25T10:33:39"], [35,"BioVac","Public Organization","South Africa","","","","","","2023-05-25T10:33:39"], [36,"BIRMEX","Public Organization","Mexico","Influenza","Seasonal Influenza; Trivalent","Influenza vaccine","Primary culture technology","","2023-05-25T10:33:39"], [37,"Boryung","Public Organization","South Korea","Influenza","Seasonal Influenza; Quadrivalent","Boryung flu V quadrivalent vaccine inj. ","Primary culture technology","","2023-05-25T10:33:39"], [38,"Boryung","Public Organization","South Korea","Influenza","Seasonal Influenza; Quadrivalent","Boryung flu VIII tetra vaccine inj.","Primary culture technology","","2023-05-25T10:33:39"], [39,"Boryung","Public Organization","South Korea","Influenza","Seasonal Influenza; Trivalent","Boryung flu vaccine V inj.","Primary culture technology","","2023-05-25T10:33:39"], [40,"Boryung","Public Organization","South Korea","Influenza","Seasonal Influenza; Trivalent","Boryung flu vaccine VIII-TF inj.","Primary culture technology","","2023-05-25T10:33:39"], [41,"Boryung","Public Organization","South Korea","IPV","IPV","IPVAX","Mammalian cell culture technology","","2023-05-25T10:33:39"], [42,"BravoVax","Public Organization","China","","","","","","2023-05-25T10:33:39"], [43,"Bul Bio - National Center of Infectious and Parasitic Diseases (BB-NCIPD)","Public Organization","Bulgaria","","","","","","2023-05-25T10:33:39"], [44,"Butantan","Public Organization","Brazil","HPV","HPV4","Vacina papilomavirus humano tipo, 6, 11, 16 e 18 (recombinante)","Microbial-based production platform","","2023-05-25T10:33:39"], [45,"Butantan","Public Organization","Brazil","Influenza","Seasonal Influenza; Trivalent","Seasonal Influenza Vaccine","Primary culture technology","","2023-05-25T10:33:39"], [46,"CanSino Biologics","Public Organization","China","Covid-19","Covid-19","Convidecia","Mammalian cell culture technology","","2023-05-25T10:33:39"], [47,"Center for Genetics Engineering and Biotechnology (CIGB)","","Cuba","Covid-19","Covid-19","Abdala","Mammalian cell culture technology","","2023-05-25T10:33:39"], [48,"Centro de Ingenieria Genetica y Biotecnologia (CIGB)","Public Organization","Cuba","","","","","","2023-05-25T10:33:39"], [49,"Changchun BCHT Biotechnology ","Public Organization","China","","","","","","2023-05-25T10:33:39"], [50,"Changchun Changsheng","Public Organization","China","Influenza","Seasonal Influenza; Quadrivalent","Influenza quadrivalent","Primary culture technology","","2023-05-25T10:33:39"], [51,"Chengdu Institute of Biological Products","Public Organization","China","","","","","","2023-05-25T10:33:39"], [52,"Chengdu Kanghua","Public Organization","China","","","","","","2023-05-25T10:33:39"], [53,"China National Biotech Group Keygen","University","China","","","","","","2023-05-25T10:33:39"], [54,"China National Biotech Group Lanzhou","University","China","Rota","Rota","LLR","Mammalian cell culture technology","","2023-05-25T10:33:39"], [55,"China National Biotech Group Shanghai","University","China","MMR","MMR","Measles, Mumps and Rubella Combined Vaccine","Mammalian cell culture technology","","2023-05-25T10:33:39"], [56,"China National Biotech Group Tiantan","University","China","","","","","","2023-05-25T10:33:39"], [57,"China National Biotech Group Wuhan","University","China","","","","","","2023-05-25T10:33:39"], [58,"Chinese Institute of Medical Biology","","China","","","","","","2023-05-25T10:33:39"], [59,"Chiron Behring Vaccines Private","Public Organization","India","","","","","","2023-05-25T10:33:39"], [60,"Chumakov Federal Scientific Center","","Russian Federation","Covid-19","Covid-19","CoviVac","Mammalian cell culture technology","","2023-05-25T10:33:39"], [61,"Clover Biopharmaceuticals","","","","","","","","2023-05-25T10:33:39"], [62,"Commonwealth Serum Laboratories (CSL)","","Australia","","","","","","2023-05-25T10:33:39"], [63,"CPL Biologicals","Public Organization","India","","","","","","2023-05-25T10:33:39"], [64,"CSL","","","","","","","","2023-05-25T10:33:39"], [65,"CureVac","Public Organization","Germany","","","","","","2023-05-25T10:33:39"], [66,"Dalian Hissen","","China","","","","","","2023-05-25T10:33:39"], [67,"DAVAC","","Viet Nam","","","","","","2023-05-25T10:33:39"], [68,"Dynavax","Public Organization","United States of America","","","","","","2023-05-25T10:33:39"], [69,"Emergent BioSolutions","Public Organization","United States of America","","","","","","2023-05-25T10:33:39"], [70,"Espromed Bio","Public Organization","Venezuela (Bolivarian Republic of)","","","","","","2023-05-25T10:33:39"], [71,"EuBiologics","Public Organization","South Korea","","","","","","2023-05-25T10:33:39"], [72,"Ezequiel Dias Foundation (FUNED)","Government","Brazil","","","","","","2023-05-25T10:33:39"], [73,"Farmeks","Public Organization","Ukraine","","","","","","2023-05-25T10:33:39"], [74,"Finlay Institute of Vaccines","","Cuba","Covid-19","Covid-19","Soberana 2","Mammalian cell culture technology","","2023-05-25T10:33:39"], [75,"Fosun Pharma","","China","","","","","","2023-05-25T10:33:39"], [76,"Fundacao Ataulpho de Paiva (FAP)","","Brazil","","","","","","2023-05-25T10:33:39"], [77,"Gamaleya","Government","Russian Federation","Covid-19","Covid-19","Sputnik Light","Mammalian cell culture technology","","2023-05-25T10:33:39"], [78,"Gamaleya","Government","Russian Federation","Covid-19","Covid-19","Sputnik V","Mammalian cell culture technology","","2023-05-25T10:33:39"], [79,"GeneOne Life Science","Public Organization","South Korea","","","","","","2023-05-25T10:33:39"], [80,"Gennova Biopharmaceuticals","Public Organization","India","","","","","","2023-05-25T10:33:39"], [81,"GlaxoSmithKline Biologicals SA","Public Organization","United Kingdom of Great Britain and Northern Ireland","DTaP-HepB-Hib-IPV","DTaP-HepB-Hib-IPV","Infanrix Hexa","Fermentation technology","","2023-05-25T10:33:39"], [82,"GlaxoSmithKline Biologicals SA","Public Organization","United Kingdom of Great Britain and Northern Ireland","DTaP-HepB-Hib-IPV","DTaP-HepB-Hib-IPV","Infanrix Hexa","Mammalian cell culture technology","","2023-05-25T10:33:39"], [83,"GlaxoSmithKline Biologicals SA","Public Organization","United Kingdom of Great Britain and Northern Ireland","HPV","HPV2","Cervarix","Baculovirus-insect cell culture technology","","2023-05-25T10:33:39"], [84,"GlaxoSmithKline Biologicals SA","Public Organization","United Kingdom of Great Britain and Northern Ireland","Influenza","Seasonal Influenza; Quadrivalent","Fluarix Quadrivalent; Fluarix Tetra; Influsplit Tetra (Northern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [85,"GlaxoSmithKline Biologicals SA","Public Organization","United Kingdom of Great Britain and Northern Ireland","Influenza","Seasonal Influenza; Trivalent","Fluarix (Northern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [86,"GlaxoSmithKline Biologicals SA","Public Organization","United Kingdom of Great Britain and Northern Ireland","IPV","IPV","POLIORIX","Mammalian cell culture technology","","2023-05-25T10:33:39"], [87,"GlaxoSmithKline Biologicals SA","Public Organization","United Kingdom of Great Britain and Northern Ireland","MMR","MMR","Priorix","Mammalian cell culture technology","","2023-05-25T10:33:39"], [88,"GlaxoSmithKline Biologicals SA","Public Organization","United Kingdom of Great Britain and Northern Ireland","Rota","Rota","Rotarix","Mammalian cell culture technology","","2023-05-25T10:33:39"], [89,"GPO-MBP","Public Organization","Thailand","Influenza","Seasonal Influenza; Trivalent","Trivalent inactivated influenza vaccine","Primary culture technology","","2023-05-25T10:33:39"], [90,"Green Cross Corporation","Public Organization","South Korea","Influenza","Seasonal Influenza; Quadrivalent","GCFLU Quadrivalent inj.","Primary culture technology","","2023-05-25T10:33:39"], [91,"Green Cross Corporation","Public Organization","South Korea","Influenza","Seasonal Influenza; Quadrivalent","GCFLU Quadrivalent Multi inj.","Primary culture technology","","2023-05-25T10:33:39"], [92,"Green Cross Corporation","Public Organization","South Korea","Influenza","Seasonal Influenza; Trivalent","GC FLU inj","Primary culture technology","","2023-05-25T10:33:39"], [93,"Green Cross Corporation","Public Organization","South Korea","Influenza","Seasonal Influenza; Trivalent","GC FLU Multi inj.","Primary culture technology","","2023-05-25T10:33:39"], [94,"GreenSignal Bio Pharma Limited","Public Organization","India","","","","","","2023-05-25T10:33:39"], [95,"Group 42 (G42)","","","","","","","","2023-05-25T10:33:39"], [96,"Haffkine Bio Pharmaceutical","Government","India","","","","","","2023-05-25T10:33:39"], [97,"HLL Biotech Limited","","India","","","","","","2023-05-25T10:33:39"], [98,"Hualan Biological Bacterin","Public Organization","China","Influenza","Seasonal Influenza; Trivalent","Influenza Vaccine (Split virion, inactivated)","Primary culture technology","","2023-05-25T10:33:39"], [99,"IBSS Biomed","Public Organization","Poland","","","","","","2023-05-25T10:33:39"], [100,"ID Biomedical Corporation of Quebec","","Canada","Influenza","Seasonal Influenza; Quadrivalent","FluLaval Quadrivalent; Flulaval Tetra (Northern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [101,"ID Biomedical Corporation of Quebec","","Canada","Influenza","Seasonal Influenza; Trivalent","Flulaval (Northern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [102,"Il-Yand Pharmaceutical","Public Organization","South Korea","Influenza","Seasonal Influenza; Trivalent","IL-YANG FLU Vaccine INJ.","Primary culture technology","","2023-05-25T10:33:39"], [103,"IMBCAMS","Government","China","Covid-19","Covid-19","SAR-CoV-2 vaccine","Mammalian cell culture technology","","2023-05-25T10:33:39"], [104,"IMBCAMS","Government","China","IPV","Sabin IPV","Inactivated Poliomyelitis Vaccine made from Sabin strains (Vero cells)","Mammalian cell culture technology","","2023-05-25T10:33:39"], [105,"Imunoloski zavod Zagreb","Government","Croatia","","","","","","2023-05-25T10:33:39"], [106,"Incepta Pharmaceuticals","Public Organization","Bangladesh","","","","","","2023-05-25T10:33:39"], [107,"Indian Immunologicals","Public Organization","India","","","","","","2023-05-25T10:33:39"], [108,"Inovio Pharmaceuticals","Public Organization","United States of America","","","","","","2023-05-25T10:33:39"], [109,"Institut Pasteur de Dakar","Public Enterprise","France","","","","","","2023-05-25T10:33:39"], [110,"Institut Pasteur de Tunis","Public Enterprise","Tunisia","","","","","","2023-05-25T10:33:39"], [111,"Institut Pasteur Iran","Public Enterprise","Iran","","","","","","2023-05-25T10:33:39"], [112,"Instituto Biológico Argentino S.A.I.C. (BIOL)","Public Organization","Argentina","","","","","","2023-05-25T10:33:39"], [113,"Intervax","Public Organization","Canada","","","","","","2023-05-25T10:33:39"], [114,"IVAC","Government","Viet Nam","","","","","","2023-05-25T10:33:39"], [115,"Janssen Pharmaceuticals","Public Organization","Belgium","Covid-19","Covid-19","Ad26.COV2.S ","Mammalian cell culture technology","","2023-05-25T10:33:39"], [116,"Japan BCG Laboratory","Public Organization","Japan","","","","","","2023-05-25T10:33:39"], [117,"Korea Vaccine","Public Organization","South Korea","Influenza","Seasonal Influenza; Quadrivalent","Kovax-flu; Kovax-Influ","Primary culture technology","","2023-05-25T10:33:39"], [118,"Korea Vaccine","Public Organization","South Korea","IPV","IPV","KOVAX POLIO PF Inj.","Mammalian cell culture technology","","2023-05-25T10:33:39"], [119,"LG Chem","Public Organization","South Korea","Influenza","Seasonal Influenza; Trivalent","Fluplus Tf Inj.","Primary culture technology","","2023-05-25T10:33:39"], [120,"LG Chem","Public Organization","South Korea","IPV","Sabin IPV","Eupolio Inj.","Mammalian cell culture technology","","2023-05-25T10:33:39"], [121,"Liaoning Chengda Biotechnology (CDBIO)","Public Organization","China","","","","","","2023-05-25T10:33:39"], [122,"M. Aikimbayev Kazakh Scientific Center of Quarantine and Zoonotic Diseases (KSCQZD)","Government","Kazakhstan","","","","","","2023-05-25T10:33:39"], [123,"MassBiologics","Public Organization","United States of America","","","","","","2023-05-25T10:33:39"], [124,"Medicago","Public Organization","United States of America","","","","","","2023-05-25T10:33:39"], [125,"Medigen Vaccine Biologics","Government","Taiwan","Covid-19","Covid-19","MVC-COV1901","","","2023-05-25T10:33:39"], [126,"MedImmune","","United States of America","Influenza","Seasonal Influenza; Quadrivalent","FluMist Quadrivalent; Fluenz Tetra (Northern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [127,"MedImmune","","United States of America","Influenza","Seasonal Influenza; Trivalent","FluMist; Fluenz (Northern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [128,"Merck Sharp & Dohme (MSD)","Public Organization","United States of America","DTaP-HepB-Hib-IPV","DTaP-HepB-Hib-IPV","Vaxelis","Fermentation technology","","2023-05-25T10:33:39"], [129,"Merck Sharp & Dohme (MSD)","Public Organization","United States of America","DTaP-HepB-Hib-IPV","DTaP-HepB-Hib-IPV","Vaxelis","Mammalian cell culture technology","","2023-05-25T10:33:39"], [130,"Merck Sharp & Dohme (MSD)","Public Organization","United States of America","HPV","HPV4","Gardasil","Microbial-based production platform","","2023-05-25T10:33:39"], [131,"Merck Sharp & Dohme (MSD)","Public Organization","United States of America","HPV","HPV9","Gardasil 9","Microbial-based production platform","","2023-05-25T10:33:39"], [132,"Merck Sharp & Dohme (MSD)","Public Organization","United States of America","MMR","MMR","rHA M-M-R II","Mammalian cell culture technology","","2023-05-25T10:33:39"], [133,"Merck Sharp & Dohme (MSD)","Public Organization","United States of America","Rota","Rota","Rotateq","Mammalian cell culture technology","","2023-05-25T10:33:39"], [134,"Microgen","Government","Russian Federation","Influenza","Seasonal Influenza; Trivalent","Grippol","Primary culture technology","","2023-05-25T10:33:39"], [135,"Microgen","Government","Russian Federation","Influenza","Seasonal Influenza; Trivalent","Sovigripp","Primary culture technology","","2023-05-25T10:33:39"], [136,"Ministry of Defense, Russia","Government","Russian Federation","","","","","","2023-05-25T10:33:39"], [137,"Moderna","Public Organization","United States of America","Covid-19","Covid-19","Spikevax","","","2023-05-25T10:33:39"], [138,"NANOLEK","Public Organization","Russian Federation","IPV","IPV","Polymilex","Mammalian cell culture technology","","2023-05-25T10:33:39"], [139,"North China Pharmaceutical Group Corp. (NCPC)","","China","","","","","","2023-05-25T10:33:39"], [140,"Novartis","Public Organization","Switzerland","Influenza","Seasonal Influenza; Trivalent","Begrivac","Primary culture technology","","2023-05-25T10:33:39"], [141,"Novavax","Public Organization","United States of America","","","","","","2023-05-25T10:33:39"], [142,"Nuron Biotech","Public Organization","United States of America","","","","","","2023-05-25T10:33:39"], [143,"Panacea Biotec","Public Organization","India","DTwP-HepB-Hib-IPV","DTwP-HepB-Hib-IPV","EasySix","Fermentation technology","","2023-05-25T10:33:39"], [144,"Panacea Biotec","Public Organization","India","DTwP-HepB-Hib-IPV","DTwP-HepB-Hib-IPV","EasySix","Mammalian cell culture technology","","2023-05-25T10:33:39"], [145,"Panacea Biotec","Public Organization","India","IPV","IPV","POLPROTEC","Mammalian cell culture technology","","2023-05-25T10:33:39"], [146,"Pasteur Institute of India","Government","India","","","","","","2023-05-25T10:33:39"], [147,"PaxVax","Public Organization","United States of America","","","","","","2023-05-25T10:33:39"], [148,"Petrovax","Public Organization","Russian Federation","Influenza","Seasonal Influenza; Quadrivalent","Grippol Quadrivalent","Primary culture technology","","2023-05-25T10:33:39"], [149,"Petrovax","Public Organization","Russian Federation","Influenza","Seasonal Influenza; Trivalent","Grippol Neo","Primary culture technology","","2023-05-25T10:33:39"], [150,"Petrovax","Public Organization","Russian Federation","Influenza","Seasonal Influenza; Trivalent","Grippol Plus","Primary culture technology","","2023-05-25T10:33:39"], [151,"Pfizer","Public Organization","United States of America","","","","","","2023-05-25T10:33:39"], [152,"Pfizer/BioNTech","","Germany","Covid-19","Covid-19","Comirnaty","","","2023-05-25T10:33:39"], [153,"POLYVAC","Government","Viet Nam","Rota","Rota","Rotavin-M1","Mammalian cell culture technology","","2023-05-25T10:33:39"], [154,"Protein Sciences Corporation","","United States of America","Influenza","Seasonal Influenza; Trivalent","Flublok (Northern hemisphere)","Baculovirus-insect cell culture technology","","2023-05-25T10:33:39"], [155,"Providence Therapeutics","","Canada","","","","","","2023-05-25T10:33:39"], [156,"PT Bio Farma (Persero)","University","Indonesia","IPV","IPV","Inactivated polio vaccine (IPV, Bulk from Sanofi Pasteur SA)","Mammalian cell culture technology","","2023-05-25T10:33:39"], [157,"Razi Institute","Public Organization","Iran","MMR","MMR","MMR","Mammalian cell culture technology","","2023-05-25T10:33:39"], [158,"Research Institute for Biological Safety Problems","","Kazakhstan","Covid-19","Covid-19","QazCovid-in","Mammalian cell culture technology","","2023-05-25T10:33:39"], [159,"Saint-Petersburg Scientific Research Institute of vaccines and sera (SPbSRIVS)","Government","Russian Federation","","","","","","2023-05-25T10:33:39"], [160,"Sanofi Pasteur","Public Organization","France","Dengue","Dengue","Dengvaxia","","","2023-05-25T10:33:39"], [161,"Sanofi Pasteur","Public Organization","France","Dengue","Dengue","DENGVAXIA TEST","other","","2023-05-25T10:33:39"], [162,"Sanofi Pasteur","Public Organization","France","DTaP-HepB-Hib-IPV","DTaP-HepB-Hib-IPV","Hexavac, Hexaxim, Hexyon","Fermentation technology","","2023-05-25T10:33:39"], [163,"Sanofi Pasteur","Public Organization","France","DTaP-HepB-Hib-IPV","DTaP-HepB-Hib-IPV","Hexavac, Hexaxim, Hexyon","Mammalian cell culture technology","","2023-05-25T10:33:39"], [164,"Sanofi Pasteur","Public Organization","France","Influenza","Seasonal Influenza; Quadrivalent","Flublok Quadrivalent (Northern hemisphere)","Baculovirus-insect cell culture technology","","2023-05-25T10:33:39"], [165,"Sanofi Pasteur","Public Organization","France","Influenza","Seasonal Influenza; Quadrivalent","Fluzone High-Dose Quadrivalent (Northern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [166,"Sanofi Pasteur","Public Organization","France","Influenza","Seasonal Influenza; Quadrivalent","Fluzone Intradermal Quadrivalent","Primary culture technology","","2023-05-25T10:33:39"], [167,"Sanofi Pasteur","Public Organization","France","Influenza","Seasonal Influenza; Quadrivalent","Fluzone Quadrivalent (Southern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [168,"Sanofi Pasteur","Public Organization","France","Influenza","Seasonal Influenza; Quadrivalent","Fluzone Quadrivalent; FluQuadri (Northern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [169,"Sanofi Pasteur","Public Organization","France","Influenza","Seasonal Influenza; Quadrivalent","VaxigripTetra","Primary culture technology","","2023-05-25T10:33:39"], [170,"Sanofi Pasteur","Public Organization","France","Influenza","Seasonal Influenza; Trivalent","Fluzone (Northern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [171,"Sanofi Pasteur","Public Organization","France","Influenza","Seasonal Influenza; Trivalent","Fluzone (Southern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [172,"Sanofi Pasteur","Public Organization","France","Influenza","Seasonal Influenza; Trivalent","Fluzone High-Dose Trivalent (Northern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [173,"Sanofi Pasteur","Public Organization","France","Influenza","Seasonal Influenza; Trivalent","Fluzone Intradermal Trivalent","Primary culture technology","","2023-05-25T10:33:39"], [174,"Sanofi Pasteur","Public Organization","France","Influenza","Seasonal Influenza; Trivalent","Vaxigrip","Primary culture technology","","2023-05-25T10:33:39"], [175,"Sanofi Pasteur","Public Organization","France","IPV","IPV","IMOVAX POLIO","Mammalian cell culture technology","","2023-05-25T10:33:39"], [176,"Sanofi Pasteur/GSK","","France","","","","","","2023-05-25T10:33:39"], [177,"Seqirus Limited","Public Organization","United Kingdom of Great Britain and Northern Ireland","Influenza","Seasonal Influenza; Quadrivalent","Afluria Quadrivalent (Northern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [178,"Seqirus Limited","Public Organization","United Kingdom of Great Britain and Northern Ireland","Influenza","Seasonal Influenza; Quadrivalent","Afluria Quadrivalent (Southern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [179,"Seqirus Limited","Public Organization","United Kingdom of Great Britain and Northern Ireland","Influenza","Seasonal Influenza; Quadrivalent","Fluad Quadrivalent (Northern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [180,"Seqirus Limited","Public Organization","United Kingdom of Great Britain and Northern Ireland","Influenza","Seasonal Influenza; Quadrivalent","Flucelvax Quadrivalent","Mammalian cell culture technology","","2023-05-25T10:33:39"], [181,"Seqirus Limited","Public Organization","United Kingdom of Great Britain and Northern Ireland","Influenza","Seasonal Influenza; Trivalent","Afluria (Northern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [182,"Seqirus Limited","Public Organization","United Kingdom of Great Britain and Northern Ireland","Influenza","Seasonal Influenza; Trivalent","Afluria (Southern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [183,"Seqirus Limited","Public Organization","United Kingdom of Great Britain and Northern Ireland","Influenza","Seasonal Influenza; Trivalent","Agriflu","Primary culture technology","","2023-05-25T10:33:39"], [184,"Seqirus Limited","Public Organization","United Kingdom of Great Britain and Northern Ireland","Influenza","Seasonal Influenza; Trivalent","Agrippal; Agrippal S1; Chiroflu; Begripal; Sandovac","Primary culture technology","","2023-05-25T10:33:39"], [185,"Seqirus Limited","Public Organization","United Kingdom of Great Britain and Northern Ireland","Influenza","Seasonal Influenza; Trivalent","Fluad (Northern hemisphere)","Primary culture technology","","2023-05-25T10:33:39"], [186,"Seqirus Limited","Public Organization","United Kingdom of Great Britain and Northern Ireland","Influenza","Seasonal Influenza; Trivalent","Fluvirin","Primary culture technology","","2023-05-25T10:33:39"], [187,"Serum Institute of India","Public Organization","India","Covid-19","Covid-19","Covishield","Mammalian cell culture technology","","2023-05-25T10:33:39"], [188,"Serum Institute of India","Public Organization","India","Influenza","Seasonal Influenza; Trivalent","Nasovac-S Influenza Vaccine, Live, Attenuated (Human)","Primary culture technology","","2023-05-25T10:33:39"], [189,"Serum Institute of India","Public Organization","India","IPV","IPV","POLIOVAC","Mammalian cell culture technology","","2023-05-25T10:33:39"], [190,"Serum Institute of India","Public Organization","India","IPV","IPV","POLIOVAC PFS","Mammalian cell culture technology","","2023-05-25T10:33:39"], [191,"Serum Institute of India","Public Organization","India","MMR","MMR","Measles,Mumps and Rubella Vaccine Live attenuated","Mammalian cell culture technology","","2023-05-25T10:33:39"], [192,"Serum Institute of India","Public Organization","India","Rota","Rota","Rotasiil","Mammalian cell culture technology","","2023-05-25T10:33:39"], [193,"Serum Institute of India","Public Organization","India","Rota","Rota","Rotasiil Thermo","Mammalian cell culture technology","","2023-05-25T10:33:39"], [194,"Serum Institute of India","Public Organization","India","Rota","Rota","Rotasiil-liquid","Mammalian cell culture technology","","2023-05-25T10:33:39"], [195,"Sevapharma A.S","Public Organization","Czechia","MMR","MMR","TRIVIVAC","Mammalian cell culture technology","","2023-05-25T10:33:39"], [196,"Shanghai Institute of Biological Products","","China","Influenza","Seasonal Influenza; Trivalent","Influenza virus split vaccine","Primary culture technology","","2023-05-25T10:33:39"], [197,"Shantha Biotechnics","Public Organization","India","IPV","IPV","ShanIPV","Mammalian cell culture technology","","2023-05-25T10:33:39"], [198,"Shifa Pharmed","","Iran","Covid-19","Covid-19","CovIran Barekat","","","2023-05-25T10:33:39"], [199,"Siam Bioscience","Public Organization","Thailand","Covid-19","Covid-19","COVID-19 Vaccine (ChAdOx1-S [recombinant])","Mammalian cell culture technology","","2023-05-25T10:33:39"], [200,"Sinergium Biotech","Public Organization","Argentina","HPV","HPV4","Silgard VPH","Microbial-based production platform","","2023-05-25T10:33:39"], [201,"Sinergium Biotech","Public Organization","Argentina","Influenza","Seasonal Influenza; Trivalent","Fluxvir","Primary culture technology","","2023-05-25T10:33:39"], [202,"Sinergium Biotech","Public Organization","Argentina","Influenza","Seasonal Influenza; Trivalent","Viraflu","Primary culture technology","","2023-05-25T10:33:39"], [203,"Sinopharm","University","China","MMR","MMR","Measles, Mumps and Rubella Combined Vaccine","Mammalian cell culture technology","","2023-05-25T10:33:39"], [204,"Sinovac Biotech","Public Organization","China","Covid-19","Covid-19","CoronaVac","Mammalian cell culture technology","","2023-05-25T10:33:39"], [205,"SK Bioscience","Public Organization","South Korea","Covid-19","Covid-19","COVID-19 Vaccine (ChAdOx1-S [recombinant])","Mammalian cell culture technology","","2023-05-25T10:33:39"], [206,"SK Bioscience","Public Organization","South Korea","Influenza","Seasonal Influenza; Quadrivalent","SKYCellflu Quadrivalent inj.","Mammalian cell culture technology","","2023-05-25T10:33:39"], [207,"SK Bioscience","Public Organization","South Korea","Influenza","Seasonal Influenza; Quadrivalent","SKYCellflu Quadrivalent Multi inj.","Mammalian cell culture technology","","2023-05-25T10:33:39"], [208,"SK Bioscience","Public Organization","South Korea","Influenza","Seasonal Influenza; Trivalent","SKYCellflu inj.","Mammalian cell culture technology","","2023-05-25T10:33:39"], [209,"SK Bioscience","Public Organization","South Korea","Influenza","Seasonal Influenza; Trivalent","SKYCellflu Multi inj.","Mammalian cell culture technology","","2023-05-25T10:33:39"], [210,"State Research Center of Virology and Biotechnology (VECTOR)","Government","Russian Federation","Covid-19","Covid-19","EpiVacCorona","Nucleic acid-based technology","","2023-05-25T10:33:39"], [211,"Staten Serum Institute","","Denmark","","","","","","2023-05-25T10:33:39"], [212,"Takeda Pharmaceutical","","Japan","","","","","","2023-05-25T10:33:39"], [213,"Thai Red Cross","Government","Thailand","","","","","","2023-05-25T10:33:39"], [214,"The Government Pharmaceutical Organization (GPO)","Government","Thailand","","","","","","2023-05-25T10:33:39"], [215,"Torlak","Government","Serbia","","","","","","2023-05-25T10:33:39"], [216,"VABIOTECH","University","Viet Nam","","","","","","2023-05-25T10:33:39"], [217,"Vacsera","Public Organization","Egypt","","","","","","2023-05-25T10:33:39"], [218,"Valneva","Public Organization","France","","","","","","2023-05-25T10:33:39"], [219,"Vaxart","Public Organization","United States of America","","","","","","2023-05-25T10:33:39"], [220,"Vaxine","Public Organization","Australia","","","","","","2023-05-25T10:33:39"], [221,"Vaxxinity","","","","","","","","2023-05-25T10:33:39"], [222,"Vector-BiAlgam","","","","","","","","2023-05-25T10:33:39"], [223,"VINS Bioproducts","Public Organization","India","","","","","","2023-05-25T10:33:39"], [224,"Walvax","Public Organization","China","","","","","","2023-05-25T10:33:39"], [225,"Xiamen Innovax Biotech","Public Organization","China","HPV","HPV2","Cecolin","Microbial-based production platform","","2023-05-25T10:33:39"], [226,"Zhejiang Pukang","Public Organization","China","","","","","","2023-05-25T10:33:39"], [227,"Zhifei Biological Products","Public Organization","China","","","","","","2023-05-25T10:33:39"], [228,"Zydus Cadila","Public Organization","India","Covid-19","Covid-19","ZyCoV-D","","","2023-05-25T10:33:39"] ]}